S

South Texas Accelerated Research Therapeutics | START San Antonio

Research site
(Unclaimed)
Location
4383 Medical Drive, San Antonio, Texas, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

9 of 11
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

This is a Phase 1 study to assess the safety and clinical activity of RO7623066 alone and in combination in patients with advanced solid tumors.

Enrolling
Advanced Solid Tumors
Drug: Olaparib
Drug: RO7623066

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patie...

Enrolling
Solid Tumors
Drug: ADRX-0706

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess safety, tolera...

Enrolling
Solid Tumors
Drug: Budigalimab
Drug: ABBV-303

CLN-619-001 is a Phase 1, open-label, multi-center study of CLN-619 alone and in combination with pembrolizumab in patients with advanced solid tumor...

Enrolling
Advanced Solid Tumor
Drug: CLN-619
Drug: Pembrolizumab

First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209...

Enrolling
Endometrial Cancer
Lymphoma, T-Cell
Drug: CPI-0209
Locations recently updated

A Study of XMT-2056 in advanced/recurrent solid tumors that express HER2.

Enrolling
HER2-positive Non-Small Cell Lung Cancer
HER2 Low Breast Cancer
Drug: XMT-2056

The purpose of this study is to test the safety of an investigational drug called CFI-402257 alone in advanced solid tumors and in combination with F...

Enrolling
Breast Cancer
Advanced Solid Tumor
Drug: CFI-402257
Drug: Fulvestrant
Locations recently updated

The purpose of this study is to assess the efficacy and safety of MK-1200 monotherapy in participants with advanced/metastatic gastric/gastroesophage...

Enrolling
Advanced Solid Tumors
Drug: Antiemetic
Biological: MK-1200

This is a Phase I open-label, multi-center study of GS-9716 tested either as monotherapy or in combination with other anti-cancer agents in patients...

Enrolling
Solid Malignancies
Drug: GS-9716
Drug: Docetaxel

Trial conditions

Cancer (7 trials)
Breast Cancer (2 trials)
Endometrial Cancer (2 trials)
Adenomyoepithelioma (1 trial)
Biliary Tract Cancer (1 trial)
Castration-Resistant Pro... (1 trial)
Clear Cell Adenocarcinoma (1 trial)
Colorectal Cancer (1 trial)
Diffuse Large B-Cell Lym... (1 trial)
Lymphoma (1 trial)

And 5 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems